XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (NASDAQ: XYN) was a blank check company that completed its initial public offering and targeted acquisition opportunities in the pharmaceutical and life sciences sector. The company filed a Form 10-Q with the SEC on August 11, 2017, reflecting its status as an active special purpose acquisition company during that period. Focused on healthcare and biopharma, XYN pursued a business combination strategy common among sector-specific SPACs of that era, with its shares listed on a major U.S. exchange. For complete filing history, deal timelines, sponsor details, and analytical data on XYN and hundreds of other SPACs, sign up for full access at SpacDesk.